Wednesday, March 2, 2016

Encouraging results from cannabidiol trial for treatment-resistant epilepsy

›
Cannabidiol (CBD), a medical marijuana derivative, was effective in reducing seizure frequency and well-tolerated and safe for most ch...
Tuesday, March 1, 2016

TIGER-X study reviews efficacy of rociletinib therapy in patients with EGFR mutant-positive NSCLC

›
Oncology & Hematology Review, the peer-reviewed journal, has published a review highlighting recent data around rociletinib, an in...
Monday, February 29, 2016

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

›
On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hyp...
Friday, February 26, 2016

Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China

›
Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison MediPharma Limited ("HMP"...
Thursday, February 25, 2016

Zoledronate drug can protect stem cells from ageing

›
In continuation of my update on  Zoledronic acid .. Stem cells can be protected from the effects of ageing by a drug currently used to...
Wednesday, February 24, 2016

Novel drug candidate prevents nerve cell damage in mouse model of Parkinson's disease

›
A team of scientists at the University of Nebraska Medical Center (UNMC) and Longevity Biotech, Inc., has demonstrated that neuroprotectio...
Tuesday, February 23, 2016

Cancer drug may protect kidneys from damage caused by chemotherapy agent cisplatin

›
In continuation of my update on cis platin ... A class of drugs used increasingly to help fight cancer may have the additional b...
Monday, February 22, 2016

Ibrutinib ‘new standard’ for relapsed, refractory mantle cell lymphoma

›
In continuation of my update on  Ibrutinib and  Temsirolimus Temsirolimus Phase III trial findings suggest that patients with relap...
Friday, February 12, 2016

Capecitabine increases disease-free survival for HER2-negative breast cancer patients

›
Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that w...

Study reveals why anti-hormone therapy tamoxifen works better in some women than others

›
In continuation of my update on  tamoxifen The anti-hormone therapy tamoxifen can reduce breast cancer recurrence by about half in w...
2 comments:
Thursday, February 11, 2016

FDA approves Vistogard (uridine triacetate) for emergency treatment of chemotherapy overdose

›
The U.S. Food and Drug Administration today approved   Vistogard   (uridine triacetate)   for the emergency treatment of adults and child...
Wednesday, February 10, 2016

Role for carfilzomib in relapsed, refractory multiple myeloma treatment

›
In continuation of my update on carfilzomib Carfilzomib significantly improves outcomes in previously treated patients with relap...
Tuesday, February 9, 2016

Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

›
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-smal...
Monday, February 8, 2016

Single dose of psilocybin decreases anxiety, depression in cancer patients

›
In continuation of my update on  Psilocybin A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induce...
Friday, February 5, 2016

New heart failure drug may increase patients' risk of Alzheimer's disease, macular degeneration

›
In continuation of my update on  sacubitril and  Valsartan Patients with mild heart failure stand to benefit from a new drug that can ...